April will see the first call for proposals under the Innovative Health Initiative, a patient-centric, demand-led project that is about to come to life for technology innovators after 30 months of negotiations and preparations by European health care industry associations and the European Commission.
Europe’s ground-breaking Innovative Health Initiative (IHI), a new Horizon Europe public-private partnership, is finally on the cusp of being fully operational. The joint EU and European life science industry associations initiative is aimed at finding innovative solutions to unmet health care needs.
The launch schedule suffered a few months’ slippage after the EU’s adoption of its general regulation on partnerships was delayed...
Launching In Vivo’s oncology therapeutic review series, this first instalment provides a data-led primer on the global cancer landscape. Future instalments will explore market dynamics, pipeline evolution and the innovations set to define oncology therapeutics through 2032.
To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.
To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.
As the planet heats up and sea levels rise, the need to reduce carbon emissions is becoming ever more urgent. The life sciences industry is just one of many that are looking to cut the carbon it produces.
Launching In Vivo’s oncology therapeutic review series, this first instalment provides a data-led primer on the global cancer landscape. Future instalments will explore market dynamics, pipeline evolution and the innovations set to define oncology therapeutics through 2032.
Launching In Vivo’s oncology therapeutic review series, this first instalment provides a data-led primer on the global cancer landscape. Future instalments will explore market dynamics, pipeline evolution and the innovations set to define oncology therapeutics through 2032.
